Buy
Average AnalystBuy
Top AnalystSlightly Bullish
Stock Target AdvisorStrong Buy
Average UserUSD 128.60
0.00 (0.00%)
USD 13.50B
1.26M
USD 114.00(-11.35%)
Based on the Intracellular Th stock forecast from 11 analysts, the average analyst target price for Intracellular Th is USD 114.00 over the next 12 months. Intracellular Th’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Intracellular Th is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Intracellular Th’s stock price was USD 128.60. Intracellular Th’s stock price has changed by +0.61% over the past week, +1.20% over the past month and +83.30% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The stock is trading high compared to its peers median on a price to book value basis.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.